Clinical trial

Travatan Versus Timoptic in Treating Open-angle Glaucoma or Ocular Hypertension

NCT00763061

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-05-01

PhasePHASE4

Study timeline

Study start (unknown)2006-05-01Date precision: month

Registry last updated2010-03-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Glaucomaunresolved

Interventions

Travoprost 0.004% Ophthalmic Solution (Travatan)DRUG

Timolol 0.5% Ophthalmic Solution (Timoptic)DRUG

Sponsors & collaborators

Alcon Researchlead sponsor

Mapped research locations

Fort WorthTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00763061 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.